Active TB · Children living with HIV receiving ART
It is very uncertain whether isoniazid prophylaxis changes active TB compared with placebo (very low certainty).
1 finding from 1 review
Death · Children living with HIV receiving ART
It is very uncertain whether isoniazid prophylaxis changes death compared with placebo (very low certainty).
1 finding from 1 review
Clinical malaria · non‐immune adults and children travelling to or living in malaria‐endemic settings
1 finding from 1 review
Vomiting · non‐immune adults and children travelling to or living in malaria‐endemic settings
Mefloquine showed no clear difference in vomiting compared with atovaquone‐proguanil; GRADE not reported.
1 finding from 1 review
Abdominal pain · non‐immune adults and children travelling to or living in malaria‐endemic settings
Mefloquine showed no clear difference in abdominal pain compared with atovaquone‐proguanil; GRADE not reported.
1 finding from 1 review
Diarrhoea · non‐immune adults and children travelling to or living in malaria‐endemic settings
Mefloquine showed no clear difference in diarrhoea compared with atovaquone‐proguanil; GRADE not reported.
1 finding from 1 review
Headache · non‐immune adults and children travelling to or living in malaria‐endemic settings
Mefloquine showed no clear difference in headache compared with atovaquone‐proguanil; GRADE not reported.
1 finding from 1 review
Dizziness · non‐immune adults and children travelling to or living in malaria‐endemic settings
Mefloquine led to higher dizziness compared with atovaquone‐proguanil; GRADE not reported.
1 finding from 1 review
Pruritis · non‐immune adults and children travelling to or living in malaria‐endemic settings
Mefloquine showed no clear difference in pruritis compared with atovaquone‐proguanil; GRADE not reported.
1 finding from 1 review
Visual impairment · non‐immune adults and children travelling to or living in malaria‐endemic settings
Mefloquine showed no clear difference in visual impairment compared with atovaquone‐proguanil; GRADE not reported.
1 finding from 1 review
Mouth ulcers · non‐immune adults and children travelling to or living in malaria‐endemic settings
Mefloquine showed no clear difference in mouth ulcers compared with atovaquone‐proguanil; GRADE not reported.
1 finding from 1 review
Clinical malaria · Non‐immune adults and children travelling to malaria‐endemic settings
Mefloquine showed no clear difference in clinical malaria compared with doxycycline; GRADE not reported.
1 finding from 1 review
Serious adverse effects · Non‐immune adults and children travelling to malaria‐endemic settings
Mefloquine showed no clear difference in serious adverse effects compared with doxycycline; GRADE not reported.
1 finding from 1 review
Serious adverse effects · non‐immune adults and children travelling to or living in malaria‐endemic settings
Mefloquine showed no clear difference in serious adverse effects compared with atovaquone‐proguanil; GRADE not reported.
1 finding from 1 review
Discontinuation of treatment due to side effects ( · Non‐immune adults and children travelling to malaria‐endemic settings
Mefloquine showed no clear difference in discontinuations due to adverse effects compared with doxycycline; GRADE not reported.
1 finding from 1 review
Abnormal dreams · Non‐immune adults and children travelling to malaria‐endemic settings
Mefloquine led to higher abnormal dreams compared with doxycycline; GRADE not reported.
1 finding from 1 review
Insomnia · Non‐immune adults and children travelling to malaria‐endemic settings
Mefloquine led to higher insomnia compared with doxycycline; GRADE not reported.
1 finding from 1 review
Anxiety · Non‐immune adults and children travelling to malaria‐endemic settings
Mefloquine led to higher anxiety compared with doxycycline; GRADE not reported.
1 finding from 1 review
Abnormal thoughts or perceptions · Non‐immune adults and children travelling to malaria‐endemic settings
Mefloquine showed no clear difference in abnormal thoughts or perceptions compared with doxycycline; GRADE not reported.
1 finding from 1 review
Nausea · Non‐immune adults and children travelling to malaria‐endemic settings
Mefloquine led to lower nausea compared with doxycycline; GRADE not reported.
1 finding from 1 review